Sort
130,381 grants matching “hiv”
A Mucosal Vaccine for HSV-2
$908,733Kejian Yang · Biomedical Research Models, Inc. · R44 · FY2010 · AI
Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder
$908,730Cathy J Reback · Friends Research Institute, Inc. · R01 · FY2023 · DA
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$908,727Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$908,705Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
HIV Database for HIV - AIDS Therapeutics and Microbicides
$908,690Margaret Rush · Gryphon Scientific, Llc · N01 · FY2013 · AI
Developing a Novel Incubator to Increase Cell Culture Reproducibility
$908,687Barry E. Rothenberg · Embrient Inc · R44 · FY2025 · TR
Behavioral Sciences Training in Drug Abuse Research
$908,632Gregory P Falkin · New York University · T32 · FY2017 · DA
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$908,629Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2009 · HL
Immune Correlates of Protection from TB
$908,608Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2019 · AI
Gene-Environment Interplay in the Development of Drug Abuse, HIV Sexual Risk Beha
$908,534Karl Gordon Hill · University Of Washington · R01 · FY2015 · DA
YMSM Drug Use, Sexual Risk &Health Promoting Behaviors
$908,349Children'S Hospital Los Angeles · R01 · FY2003 · DA
Clinical Study to Measure Pharmacokinetics, Pharmacodynamics and Safety of a TDF
$908,327Marla J Keller · Albert Einstein College Of Medicine · U19 · FY2012 · AI
Optimizing Oral Pediatric HIV Vaccines to Prevent Breast Milk Transmission
$908,245Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2016 · DE
Defining Drivers of HPV-associated Carcinogenesis
$908,100Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2023 · CA
Health and Aging in Africa: Longitudinal Studies of INDEPTH Communities
$907,898Lisa F Berkman · Harvard School Of Public Health · P01 · FY2013 · AG
Commercial Readiness for SAMBA HIV-1 Whole Blood Semi-Quantitative Test for Resource Limited Settings
$907,877Helen H Lee · Diagnostics For The Real World, Ltd · SB1 · FY2017 · AI
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$907,829Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center
$907,674Elizabeth Renata Brown · University Of Washington · R01 · FY2010 · HL
CD180 targeted immunotherapeutic for chronic HBV in HIV infected patients
$907,661Deborah L. Fuller · University Of Washington · R56 · FY2019 · AI
Administrative Core
$907,518Bruce D Walker · Harvard University · P30 · FY2020 · AI
Immunopathogenesis Of Chlamydia trachomatis Infection
$907,514Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Focal Segmental Glomerulosclerosis: Genetics & Mechanisms
$907,508Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Novel Concepts for the Eradication of HIV
$907,484Rafick-Pierre Sekaly · Vgti Florida · DP1 · FY2011 · DA
Novel Concepts for the Eradication of HIV
$907,484Rafick-Pierre Sekaly · Vgti Florida · DP1 · FY2012 · DA
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
$907,453Mohamed Abdel Mohsen · Wistar Institute · R01 · FY2020 · NS